Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GZ389988 in Painful Knee Osteoarthritis
NCT02424942Phase 1Completed
- Sponsor
- Sanofi
- Start
- Apr 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in osteoarthritis (OA) comparing GZ389988 with Placebo (2 arms). Primary endpoints: Proportion of patients with adverse events and Proportion of patients with serious adverse events. Started Apr 2015; status: completed.
02
Drugs
GZ-389988
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02424942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424942.